Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Santiago Grau

Showing results (1-10 of 214) with videos related to

Pageof 22
Sort By:
Enfermedades Infecciosas Y Microbiologia Clinica|January 29, 2017
[Main variables in the economic cost of treating an infection]Santiago Grau
Revista Iberoamericana De Micologia|July 17, 2016
The Delphi method applied to fungal infection: There is still some way to goSantiago Grau
Enfermedades Infecciosas Y Microbiologia Clinica|July 6, 2012
[Impact of studies on antimicrobial consumption on the appropriate use of antimicrobials in a hospital setting]Santiago Grau
Enfermedades Infecciosas Y Microbiologia Clinica|April 12, 2015
Antifungal therapeutic drug monitoring: when, how, and whySantiago Grau, Sònia Luque
Expert Opinion on Pharmacotherapy|March 6, 2010
Pharmacoeconomics of voriconazoleCarlos Rubio-Terrés, Santiago Grau
The Journal of Antimicrobial Chemotherapy|July 12, 2014
Comment on: Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemiaDavid Conde-Estévez, Santiago Grau
Drugs|February 7, 2012
Management of antimicrobial use in the intensive care unitFrancisco Álvarez-Lerma, Santiago Grau
Expert Opinion on Pharmacotherapy|April 2, 2008
Pharmacoeconomics of linezolidSantiago Grau, Carlos Rubio-Terrés
Expert Review of Anti-Infective Therapy|December 13, 2021
Ivermectin: a pathway out of the pandemic or another dead end?Daniel Echeverría-Esnal, Santiago Grau
Drug Design, Development and Therapy|January 6, 2017
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infectionsOlivia Ferrández, Olatz Urbina, Santiago Grau
Pageof 22

Showing results (1-10 of 214) with videos related to

Sort By:
Pageof 22
Enfermedades Infecciosas Y Microbiologia Clinica|January 29, 2017
[Main variables in the economic cost of treating an infection]Santiago Grau
Revista Iberoamericana De Micologia|July 17, 2016
The Delphi method applied to fungal infection: There is still some way to goSantiago Grau
Enfermedades Infecciosas Y Microbiologia Clinica|July 6, 2012
[Impact of studies on antimicrobial consumption on the appropriate use of antimicrobials in a hospital setting]Santiago Grau
Enfermedades Infecciosas Y Microbiologia Clinica|April 12, 2015
Antifungal therapeutic drug monitoring: when, how, and whySantiago Grau, Sònia Luque
Expert Opinion on Pharmacotherapy|March 6, 2010
Pharmacoeconomics of voriconazoleCarlos Rubio-Terrés, Santiago Grau
The Journal of Antimicrobial Chemotherapy|July 12, 2014
Comment on: Glycopeptide use is associated with increased mortality in Enterococcus faecalis bacteraemiaDavid Conde-Estévez, Santiago Grau
Drugs|February 7, 2012
Management of antimicrobial use in the intensive care unitFrancisco Álvarez-Lerma, Santiago Grau
Expert Opinion on Pharmacotherapy|April 2, 2008
Pharmacoeconomics of linezolidSantiago Grau, Carlos Rubio-Terrés
Expert Review of Anti-Infective Therapy|December 13, 2021
Ivermectin: a pathway out of the pandemic or another dead end?Daniel Echeverría-Esnal, Santiago Grau
Drug Design, Development and Therapy|January 6, 2017
Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infectionsOlivia Ferrández, Olatz Urbina, Santiago Grau
Pageof 22